Avicanna Inc(AVCN-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.1250
Day High0.1300
Open:0.1250
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
INK Research
Public market insider buying at Avicanna (AVCN)
Company Chart of AVCN
GlobeNewswire
Avicanna Reports Q1 2026 Financial Statements
GlobeNewswire
Avicanna Announces Results of Annual General and Special Meeting
GlobeNewswire
Avicanna Announces Change in Board of Directors
GlobeNewswire
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
Baystreet
Stocks in play: Avicanna Inc.
GlobeNewswire
Annual General and Special Meeting of Shareholders to be held May 7, 2026
GlobeNewswire
Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics
GlobeNewswire
Avicanna Announces Changes to its Board of Directors
Newsfile
Upcoming Meeting Dates - April 6, 2026
GlobeNewswire
Avicanna Reports Full Year 2025 Audited Financial Statements
GlobeNewswire
Avicanna Subsidiary SMGH Completes First Commercial Export to Australia
Baystreet
Stocks in play: Avicanna Inc.
GlobeNewswire
Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
GlobeNewswire
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Newsfile
Upcoming Meeting Dates - March 9, 2026
GlobeNewswire
Avicanna Announces Medical Cannabis Real World Evidence Results and Publication

Profile

Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.